Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ATM (phospho S1981) polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | Dot-Pep |
More info about ATM (phospho S1981) polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB1656 |
| Product name: | ATM (phospho S1981) polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic phosphopeptide of ATM. |
| Gene id: | 472 |
| Gene name: | ATM |
| Gene alias: | AT1|ATA|ATC|ATD|ATDC|ATE|DKFZp781A0353|MGC74674|TEL1|TELO1 |
| Gene description: | ataxia telangiectasia mutated |
| Immunogen: | Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding S1981 of human ATM. |
| Protein accession: | NP_000042;Q13315 |
| Form: | Liquid |
| Recommend dilutions: | Dot Blot (1:500) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Dot blot analysis of ATM (phospho S1981) polyclonal antibody (Cat # PAB1656) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. |
| Applications: | Dot-Pep |
| Shipping condition: | Dry Ice |
| Publications: | ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.Brunet J, Gutierrez-Enriquez S, Torres A, Berez V, Sanjose S, Galceran J, Izquierdo A, Menendez JA, Guma J, Borras J. Clin Genet. 2008 May;73(5):465-73. Epub 2008 Apr 2. |